Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Plasma-derived Factor VIII Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Plasma-derived Factor VIII Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 200IU
      • 1.3.3 250IU
    • 1.4 Market Segment by Application
      • 1.4.1 Global Plasma-derived Factor VIII Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Pharmacy
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Plasma-derived Factor VIII Market Size
      • 2.1.1 Global Plasma-derived Factor VIII Revenue 2014-2025
      • 2.1.2 Global Plasma-derived Factor VIII Sales 2014-2025
    • 2.2 Plasma-derived Factor VIII Growth Rate by Regions
      • 2.2.1 Global Plasma-derived Factor VIII Sales by Regions 2014-2019
      • 2.2.2 Global Plasma-derived Factor VIII Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Plasma-derived Factor VIII Sales by Manufacturers
      • 3.1.1 Plasma-derived Factor VIII Sales by Manufacturers 2014-2019
      • 3.1.2 Plasma-derived Factor VIII Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Plasma-derived Factor VIII Revenue by Manufacturers (2014-2019)
      • 3.2.2 Plasma-derived Factor VIII Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Plasma-derived Factor VIII Market Concentration Ratio (CR5 and HHI)
    • 3.3 Plasma-derived Factor VIII Price by Manufacturers
    • 3.4 Key Manufacturers Plasma-derived Factor VIII Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Plasma-derived Factor VIII Market
    • 3.6 Key Manufacturers Plasma-derived Factor VIII Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 200IU Sales and Revenue (2014-2019)
      • 4.1.2 250IU Sales and Revenue (2014-2019)
    • 4.2 Global Plasma-derived Factor VIII Sales Market Share by Type
    • 4.3 Global Plasma-derived Factor VIII Revenue Market Share by Type
    • 4.4 Plasma-derived Factor VIII Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Plasma-derived Factor VIII Sales by Application

    6 United States

    • 6.1 United States Plasma-derived Factor VIII Breakdown Data by Company
    • 6.2 United States Plasma-derived Factor VIII Breakdown Data by Type
    • 6.3 United States Plasma-derived Factor VIII Breakdown Data by Application

    7 European Union

    • 7.1 European Union Plasma-derived Factor VIII Breakdown Data by Company
    • 7.2 European Union Plasma-derived Factor VIII Breakdown Data by Type
    • 7.3 European Union Plasma-derived Factor VIII Breakdown Data by Application

    8 China

    • 8.1 China Plasma-derived Factor VIII Breakdown Data by Company
    • 8.2 China Plasma-derived Factor VIII Breakdown Data by Type
    • 8.3 China Plasma-derived Factor VIII Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Plasma-derived Factor VIII Breakdown Data by Company
    • 9.2 Rest of World Plasma-derived Factor VIII Breakdown Data by Type
    • 9.3 Rest of World Plasma-derived Factor VIII Breakdown Data by Application
    • 9.4 Rest of World Plasma-derived Factor VIII Breakdown Data by Countries
      • 9.4.1 Rest of World Plasma-derived Factor VIII Sales by Countries
      • 9.4.2 Rest of World Plasma-derived Factor VIII Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Shire (Baxter)
      • 10.1.1 Shire (Baxter) Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Plasma-derived Factor VIII
      • 10.1.4 Plasma-derived Factor VIII Product Introduction
      • 10.1.5 Shire (Baxter) Recent Development
    • 10.2 Octapharma
      • 10.2.1 Octapharma Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Plasma-derived Factor VIII
      • 10.2.4 Plasma-derived Factor VIII Product Introduction
      • 10.2.5 Octapharma Recent Development
    • 10.3 CSL
      • 10.3.1 CSL Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Plasma-derived Factor VIII
      • 10.3.4 Plasma-derived Factor VIII Product Introduction
      • 10.3.5 CSL Recent Development
    • 10.4 Grifols
      • 10.4.1 Grifols Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Plasma-derived Factor VIII
      • 10.4.4 Plasma-derived Factor VIII Product Introduction
      • 10.4.5 Grifols Recent Development
    • 10.5 Greencross
      • 10.5.1 Greencross Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Plasma-derived Factor VIII
      • 10.5.4 Plasma-derived Factor VIII Product Introduction
      • 10.5.5 Greencross Recent Development
    • 10.6 Kedrion
      • 10.6.1 Kedrion Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Plasma-derived Factor VIII
      • 10.6.4 Plasma-derived Factor VIII Product Introduction
      • 10.6.5 Kedrion Recent Development
    • 10.7 BPL
      • 10.7.1 BPL Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Plasma-derived Factor VIII
      • 10.7.4 Plasma-derived Factor VIII Product Introduction
      • 10.7.5 BPL Recent Development
    • 10.8 Hualan Bio
      • 10.8.1 Hualan Bio Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Plasma-derived Factor VIII
      • 10.8.4 Plasma-derived Factor VIII Product Introduction
      • 10.8.5 Hualan Bio Recent Development
    • 10.9 RAAS
      • 10.9.1 RAAS Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Plasma-derived Factor VIII
      • 10.9.4 Plasma-derived Factor VIII Product Introduction
      • 10.9.5 RAAS Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Plasma-derived Factor VIII Sales Channels
      • 11.2.2 Plasma-derived Factor VIII Distributors
    • 11.3 Plasma-derived Factor VIII Customers

    12 Market Forecast

    • 12.1 Global Plasma-derived Factor VIII Sales and Revenue Forecast 2019-2025
    • 12.2 Global Plasma-derived Factor VIII Sales Forecast by Type
    • 12.3 Global Plasma-derived Factor VIII Sales Forecast by Application
    • 12.4 Plasma-derived Factor VIII Forecast by Regions
      • 12.4.1 Global Plasma-derived Factor VIII Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Plasma-derived Factor VIII Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Plasma-derived Factor VIII is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Plasma-derived Factor VIII.

      This report studies the global market size of Plasma-derived Factor VIII, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Plasma-derived Factor VIII sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Shire (Baxter)
      Octapharma
      CSL
      Grifols
      Greencross
      Kedrion
      BPL
      Hualan Bio
      RAAS

      Market Segment by Product Type
      200IU
      250IU

      Market Segment by Application
      Hospital
      Pharmacy

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Plasma-derived Factor VIII status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Plasma-derived Factor VIII manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Plasma-derived Factor VIII are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now